Literature DB >> 5384468

Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia.

H E Skipper, F M Schabel, M W Trader, W R Laster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5384468

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  6 in total

1.  [Proliferation inhibition of AKR mouse leukemia in vivo using calf splenic extract (lymphocytic chalone)].

Authors:  E Heidemann; H Ganser; N Podgornik; H Rutsch; K Wilms; F Wörz
Journal:  Blut       Date:  1977-05

2.  Evaluation of p-F-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met-ethoxy HCl against transplantable and spontaneous murine neoplasia.

Authors:  M J Yagi; J G Bekesi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  In vivo cell kinetic effects of vincristine on the spontaneous AKR leukemia: recruitment of non-proliferating cells.

Authors:  K Hiller; P Meyer; K Wilms
Journal:  Blut       Date:  1982-07

4.  Immunotherapy in the treatment of acute myelogenous leukemia (AML): rationale, results and future prospects.

Authors:  D Urbanitz; T Büchner; H Pielken; J van de Loo
Journal:  Klin Wochenschr       Date:  1983-10-03

Review 5.  Animal models of leukemia: any closer to the real thing?

Authors:  Guerry J Cook; Timothy S Pardee
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

6.  Haemopoietic stem cells in leukaemic AKR mice: the (AKR x C57BL/6)F1 mouse as an in vivo assay system.

Authors:  G N Schwartz; S S Boggs
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.